Ambulance :: 80% of Ambulance Control Room Staff Experience Verbal Abuse
Four out of five ambulance control room staff are verbally abused by callers during a shift, suggests a small study in Emergency Medicine Journal.
Four out of five ambulance control room staff are verbally abused by callers during a shift, suggests a small study in Emergency Medicine Journal.
Elsevier, the world-leading science and medical publisher, today introduced the 5th edition of Wilderness Medicine, the definitive clinical reference on its unique subject.
Patients can’t tell the difference between hospital walk-in centres and traditional emergency care departments, says research in Emergency Medicine Journal.
A fibrous protein called fibrinogen, found in circulating blood and important in blood clotting, can promote multiple sclerosis (MS) when it leaks from the blood into the brain, triggering inflammation that leads to MS-related nerve damage.
Traditional Chinese medical beliefs continue to have an impact on oral health in Beijing, China, says Jacqueline Hom, a dental student at the Harvard School of Dental Medicine (Boston, MA, USA), who reports her findings today during the 85th General Session of the International Association for Dental Research.
Today, during the 85th General Session of the International Association for Dental Research, scientists are reporting that they have developed a method for the effective healing of, and relief of pain associated with, canker sores.
Researchers at the Johns Hopkins School of Medicine and their colleagues have found that mice simply expressing a human light receptor in addition to their own can acquire new color vision, a sign that the brain can adapt far more rapidly to new sensory information than anticipated.
Geneticists have discovered a new gene that may put individuals at higher risk of developing cardiovascular disease.
The University of Rochester Medical Center (URMC) and T.I.E.S., LLC a Rochester, New York-based start-up company, have entered into a research partnership to evaluate a new technology that could ultimately represent a major advance in medical imaging.
Sutent (sunitinib malate) has received a European Association of Urology recommendation, as first-line therapy in patients with metastatic renal cell carcinoma of good and intermediate risk, just two months after gaining EU marketing authorization for first line use in all patients with advanced and/or metastatic renal cell carcinoma.